Genus, Meet Species: Court Weighs Novo Nordisk’s Semaglutide Patent
Novo Nordisk A/S took Dr Reddy's Laboratories to the Delhi High Court over its Semaglutide patent, seeking to block generic imports of the anti-diabetic drug. Would the court…
GLP-1 analog
1 article